PMID: 8971103Dec 1, 1996Paper

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease

Journal of Neurology, Neurosurgery, and Psychiatry
C HolmesSimon Lovestone

Abstract

To determine the association between the epsilon2 and epsilon4 alleles of apolipoprotein E (ApoE) and independent measures of cognitive decline and non-cognitive symptomatology in late onset Alzheimer's disease. The frequency of the epsilon2 and epsilon4 alleles of ApoE and their association with measures of cognitive decline and non-cognitive symptomatology were assessed in a population based case register study of 164 patients with late onset Alzheimer's disease from the east Lambeth and south Southwark districts of south London. Analysis of a wide range of non-cognitive symptoms against ApoE epsilon4 genotype showed no significant association but a positive relation was found between ApoE epsilon2 genotype and depressive symptomatology (P = 0.004). No relation was found between measurements of cognitive decline and the presence of the ApoE epsilon4 allele. A trend for decreasing age at onset of 3 to 4 years in carriers of the ApoE epsilon4 allele was found, confirming earlier studies. Presence of the epsilon4 allele of ApoE is associated with an earlier age at onset but does not seem to be related to either a more severe psychopathology or a more rapid progression of the illness. The epsilon2 allele of ApoE is associated wit...Continue Reading

References

May 11, 1991·Lancet·P R WenhamG Blandell
Feb 1, 1988·Biological Psychiatry·G S AlexopoulosC A Shamoian
Jul 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G BlessedM Roth
Jul 1, 1966·Journal of Gerontology·B Meer, J A Baker
Jun 1, 1982·Acta Neurologica Scandinavica·P K MölsäU K Rinne
Jan 9, 1993·Lancet·R E MorganD L Wingard
Jan 1, 1994·Nature Genetics·F SchächterD Cohen

❮ Previous
Next ❯

Citations

Aug 21, 2013·Current Neurology and Neuroscience Reports·Giuseppe Tosto, Christiane Reitz
Mar 12, 1998·Biological Psychiatry·C HolmesS Lovestone
Mar 11, 1999·Biological Psychiatry·M L LevyG W Small
Jan 9, 2004·La Revue de médecine interne·C DumontB Vellas
Jun 18, 2002·Ageing Research Reviews·Jonathan D Smith
Jul 11, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marina Del PretePaola Angelelli
Jan 16, 2014·International Review of Psychiatry·Alessandro SonaDavid Ames
May 12, 2011·International Journal of Alzheimer's Disease·Francesco PanzaAlberto Pilotto
Apr 9, 2016·Future Neurology·Christiane Reitz
Aug 1, 2011·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Suk Ling Ma, Linda Chiu Wa Lam
Jul 15, 2016·PloS One·Luise Christine LöweUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Apr 9, 2002·Journal of Geriatric Psychiatry and Neurology·Chia-Yih LiuHsiu-Chih Liu
Apr 26, 2006·American Journal of Alzheimer's Disease and Other Dementias·Linda C W LamHelen F K Chiu
Sep 12, 2003·Journal of Geriatric Psychiatry and Neurology·Jordi ClarimónDavid Comas
Sep 11, 2002·International Journal of Geriatric Psychiatry·Amanda Thompsell, Simon Lovestone
May 8, 2002·International Journal of Geriatric Psychiatry·Martine VercellettoMichel Bourin
Sep 10, 2011·International Journal of Geriatric Psychiatry·Grazia D'OnofrioAlberto Pilotto
Nov 13, 2009·Annals of the New York Academy of Sciences·Christiane Reitz, Richard Mayeux
Feb 16, 2006·International Journal of Geriatric Psychiatry·Abdalla BowirratGiancarlo Logroscino
Jan 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M B LiddellM J Owen
Jul 16, 2010·Expert Review of Molecular Diagnostics·Thomas ZetzscheHarald Hampel
Sep 17, 2010·International Journal of Geriatric Psychiatry·Charlotte L Allan, Klaus P Ebmeier
Jun 26, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Myuri RuthirakuhanNathan Herrmann
Jan 31, 2015·Expert Review of Molecular Diagnostics·Christiane Reitz
Feb 28, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jianping JiaYi Tang
Jan 19, 2021·Journal of Alzheimer's Disease : JAD·David A Loeffler
Sep 14, 2016·Molecular and Cellular Probes·Giuseppe Tosto, Christiane Reitz
Mar 16, 2021·International Psychogeriatrics·Inès Yoro-ZohounMaëlenn Guerchet
Jun 15, 2021·Journal of Alzheimer's Disease : JAD·X Richard ChenUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.